We are live on ! Find out more
SGMO

SANGAMO THERAPEUTICS INC
SGMO

Delisted

SGMO was delisted on the 4th of May, 2026.

Back to rankings

185 hedge funds and large institutions have $860M invested in SANGAMO THERAPEUTICS INC in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 39

67% more call options, than puts

Call options by funds: $26.2M | Put options by funds: $15.7M

36% more capital invested

Capital invested by funds: $630M → $860M (+$230M)

4.74% more ownership

Funds ownership: 64.51% → 69.25% (+4.7%)

6% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 31

1% less funds holding

Funds holding: 187 → 185 (-2)

Holders
185
Holders Change
-2
Holders Change %
-1.07%
% of All Funds
4.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
76
Reduced
39
Closed
31
Calls
$26.2M
Puts
$15.7M
Net Calls
+$10.5M
Net Calls Change
+$2.07M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$71.5M
2
BG
Bellevue Group
Switzerland
+$38.8M
3
Citadel Advisors
Citadel Advisors
Florida
+$17.6M
4
BlackRock
BlackRock
New York
+$11.7M
5
N
Nuveen
North Carolina
+$8.41M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$9.23M
2
State Street
State Street
Massachusetts
-$5.37M
3
Renaissance Technologies
Renaissance Technologies
New York
-$2.96M
4
Bank of America
Bank of America
North Carolina
-$2.07M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$119M +$71.5M +6,726,532 +156%
BlackRock
2
BlackRock
New York
$102M +$11.7M +1,098,030 +13%
Vanguard Group
3
Vanguard Group
Pennsylvania
$89.5M +$6.34M +596,573 +8%
WA
4
Wasatch Advisors
Utah
$71.1M +$1.71M +161,000 +3%
State Street
5
State Street
Massachusetts
$57.6M -$5.37M -504,733 -9%
BG
6
Bellevue Group
Switzerland
$39.3M +$38.8M +3,650,000 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$28.9M +$2.5M +234,700 +10%
CS
8
Credit Suisse
Switzerland
$25.5M +$192K +18,068 +0.8%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$21.1M +$4.7M +441,744 +29%
Citadel Advisors
10
Citadel Advisors
Florida
$20.5M +$17.6M +1,650,290 +643%
CC
11
Casdin Capital
New York
$16.5M +$4.79M +450,000 +42%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$16M +$2.49M +233,677 +19%
Deutsche Bank
13
Deutsche Bank
Germany
$15.7M +$5.12M +481,525 +49%
Northern Trust
14
Northern Trust
Illinois
$14.8M +$544K +51,137 +4%
Goldman Sachs
15
Goldman Sachs
New York
$12.9M -$19.4K -1,826 -0.2%
BBA
16
Baker Bros. Advisors
New York
$10.8M – – –
AC
17
Alexandria Capital
Virginia
$9.83M -$33.5K -3,150 -0.3%
Wells Fargo
18
Wells Fargo
California
$8.85M +$1.75M +164,784 +25%
UBS AM
19
UBS AM
Illinois
$8.61M +$1.07M +100,473 +14%
RPAM
20
Rhenman & Partners Asset Management
Sweden
$8.55M -$532K -50,000 -6%
N
21
Nuveen
North Carolina
$8.52M +$8.41M +790,682 New
Charles Schwab
22
Charles Schwab
California
$7.29M +$922K +86,660 +15%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$6.92M +$5.37M +505,111 +369%
PAMU
24
Pictet Asset Management (UK)
United Kingdom
$6.84M +$2.13M +200,000 +46%
Renaissance Technologies
25
Renaissance Technologies
New York
$6.75M -$2.96M -278,400 -31%
1
2 3 4 5

SGMO Hedge Fund Activity: Q2 2019 in Review

185 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q2 2019, worth a combined $860M — up 36% from $630M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new SGMO positions and 31 closed out — a net gain of 2 holders — while 76 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $71.5M. The largest seller was Invesco, cutting an estimated $9.23M.

  • 185 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q2 2019, down from 187 in Q1 2019.
  • Funds reported $860M of SANGAMO THERAPEUTICS INC stock for Q2 2019, up 36% quarter-over-quarter.
  • 33 funds opened new SANGAMO THERAPEUTICS INC positions in Q2 2019 and 31 closed out, a net change of +2 holders.
  • The largest SANGAMO THERAPEUTICS INC buyer in Q2 2019 was Wellington Management Group, an estimated $71.5M added.
  • The largest SANGAMO THERAPEUTICS INC seller in Q2 2019 was Invesco, an estimated $9.23M sold.

Based on aggregated 13F filings for Q2 2019.